GlaxoSmithKline Target of Unusually High Options Trading (GSK)

Share on StockTwits

Shares of GlaxoSmithKline (NYSE:GSK) saw unusually large options trading activity on Tuesday. Traders bought 34,680 call options on the company, American Banking News.com reports. This is an increase of approximately 1,486% compared to the average volume of 2,187 call options.

GSK has been the subject of a number of recent research reports. Analysts at Barclays reiterated an “equal weight” rating on shares of GlaxoSmithKline in a research note on Friday. Separately, analysts at Citigroup Inc. reiterated a “neutral” rating on shares of GlaxoSmithKline in a research note on Wednesday, February 12th. Finally, analysts at Zacks reiterated a “neutral” rating on shares of GlaxoSmithKline in a research note on Friday, February 7th. They now have a $55.00 price target on the stock. Three research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and four have given a buy rating to the company’s stock. GlaxoSmithKline has a consensus rating of “Hold” and an average price target of $88.67.

GlaxoSmithKline (NYSE:GSK) traded up 1.38% on Tuesday, hitting $56.66. The stock had a trading volume of 3,072,284 shares. GlaxoSmithKline has a 1-year low of $43.68 and a 1-year high of $55.91. The stock has a 50-day moving average of $53.13 and a 200-day moving average of $52.00. The company has a market cap of $135.7 billion and a price-to-earnings ratio of 15.73.

GlaxoSmithKline (NYSE:GSK) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.30 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.30. The company had revenue of $6.91 billion for the quarter, compared to the consensus estimate of $6.84 billion. GlaxoSmithKline’s revenue was up 1.5% compared to the same quarter last year. Analysts expect that GlaxoSmithKline will post $3.72 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Thursday, April 10th. Stockholders of record on Friday, February 21st will be paid a dividend of $0.7496 per share. This represents a $3.00 annualized dividend and a dividend yield of 5.36%. The ex-dividend date is Wednesday, February 19th.

GlaxoSmithKline plc (NYSE:GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.

Latest News

Proctor & Gamble Trimming Costs, Sales Fall
Proctor & Gamble Trimming Costs, Sales Fall
Netflix Set to Increase Subscription Price
Netflix Set to Increase Subscription Price
Hasbro Profit Helped by Girls Toys
Hasbro Profit Helped by Girls Toys
LinkedIn Reaches Milestone of 300 Million Members
LinkedIn Reaches Milestone of 300 Million Members
IBM Revenues Disappoint For Another Quarter
IBM Revenues Disappoint For Another Quarter
Walmart Enters the Business of Money Transfers
Walmart Enters the Business of Money Transfers


Leave a Reply

 
 
© 2006-2014 Ticker Report. Google+. Subscribe
X

Receive Analysts' Upgrades and Downgrades in Your Inbox Daily